Paclitaxel and Flomax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paclitaxel (paclitaxel) and Flomax (tamsulosin hydrochloride). Common drug interactions include reticulocytopenia among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Paclitaxel and Flomax. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

What is Flomax?

Flomax has active ingredients of tamsulosin hydrochloride. It is often used in enlarged prostate. eHealthMe is studying from 52,865 Flomax users. Check the latest studies of Flomax.



On Jul, 24, 2026

92 people who take Paclitaxel and Flomax together, and have interactions are studied.

Paclitaxel and Flomax drug interactions.

What are the common drug interactions of Paclitaxel and Flomax, by gender? *:

female:

  1. Reticulocytopenia (an abnormal decrease of reticulocytes in the body)
  2. Splenomegaly (enlargement of spleen)
  3. Streptococcal bacteraemia (a bacterial infection of blood)
  4. Syncope (loss of consciousness with an inability to maintain postural tone)
  5. Therapeutic response decreased (less preventive response)
  6. Urinary tract infection
  7. Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
  8. Decreased interest
  9. Fatigue (feeling of tiredness)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Pyrexia (fever)
  2. Chest pain
  3. Anxiety
  4. Dehydration (dryness resulting from the removal of water)
  5. Depression
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Infection
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Pneumonia
  10. Anaemia (lack of blood)

What are the common drug interactions of Paclitaxel and Flomax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anxiety
  2. Asthenia (weakness)
  3. Bone disorder
  4. Chest pain
  5. Decreased interest
  6. Depression
  7. Dysuria (painful or difficult urination)
  8. Erectile dysfunction
  9. Fatigue (feeling of tiredness)
  10. Gynaecomastia (enlargement of the gland tissue of the male breast)

50-59:

  1. Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
  2. Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
  3. Reticulocytopenia (an abnormal decrease of reticulocytes in the body)
  4. Splenomegaly (enlargement of spleen)
  5. Streptococcal bacteraemia (a bacterial infection of blood)
  6. Therapeutic response decreased (less preventive response)
  7. Varices oesophageal (enlarged and swollen veins at the bottom of the oesophagus, near the stomach)
  8. Dehydration (dryness resulting from the removal of water)
  9. Syncope (loss of consciousness with an inability to maintain postural tone)
  10. Dyspnoea (difficult or laboured respiration)

60+:

  1. Pyrexia (fever)
  2. Fatigue (feeling of tiredness)
  3. Atelectasis (partial or complete collapse of the lung)
  4. Cardiac failure congestive
  5. Cardiomyopathy (weakening of the heart muscle)
  6. Chest pain
  7. Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
  8. Ejection fraction decreased (systolic heart failure)
  9. Gastritis atrophic (process of chronic inflammation of the stomach mucosa)
  10. Oesophagitis (inflammation of oesophagus)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 20 people, 21.74%
  2. Pain: 16 people, 17.39%
  3. Prostate Cancer: 14 people, 15.22%
  4. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 11 people, 11.96%
  5. Weakness: 10 people, 10.87%
  6. Hypoaesthesia (reduced sense of touch or sensation): 10 people, 10.87%
  7. High Blood Pressure: 9 people, 9.78%
  8. Urinary Retention (the inability to completely or partially empty the bladder): 7 people, 7.61%
  9. Diabetes: 7 people, 7.61%
  10. Stress And Anxiety: 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Paclitaxel and Flomax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Paclitaxel and Flomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paclitaxel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flomax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel and tamsulosin hydrochloride (the active ingredients of Paclitaxel and Flomax, respectively), and Paclitaxel and Flomax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: